Source: Contract Pharma

Cobra: Cobra Biologics Delivers Plasmids for CombiGene's Epilepsy Candidate

Completes delivery of all plasmids required to progress to the next phase of the project.

Read full article »
Cobra's Competitors | Cobra's News | Cobra's Financials
Stay up-to-date with the latest news on Cobra Biologics
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100

Read more
Stay up-to-date with the latest news on Cobra Biologics